In addition to measuring insulin levels, an insulin blood test can also help assess insulin resistance, a condition where cells do not respond effectively to insulin, leading to an increase in blood sugar levels. This is often a precursor to type 2 diabetes.
Monitoring insulin levels is essential for individuals with diabetes, as it helps healthcare providers determine the appropriate dosage of insulin or other medications to control blood sugar levels. Regular insulin blood tests can also help track changes in insulin production over time.
It’s important to fast before an insulin blood test, as food intake can affect insulin levels. Your healthcare provider may recommend specific instructions to follow before the test, such as fasting for a certain period of time.
Overall, an insulin blood test is a valuable tool in evaluating insulin function, detecting insulin-related disorders, and managing diabetes effectively.
Uses of Insulin Blood Test
An insulin blood test assists in:
- Identifying the cause of hypoglycemia.
- Detecting insulin resistance and guiding treatment decisions for type 2 diabetes.
- Monitoring the success of pancreatic islet cell transplantations.
- Evaluating insulin levels in individuals with polycystic ovary syndrome (PCOS).
- Assessing insulin production in individuals with suspected insulinoma.
When Do You Need an Insulin Blood Test?
You may require an insulin blood test if experiencing low blood glucose levels or symptoms of hypoglycemia. Severe cases of hypoglycemia may lead to fainting and seizures, necessitating urgent medical attention.
- Prediabetes or type 2 diabetes.
- Acanthosis nigricans.
- Islet cell transplantation or removal of insulinoma.
How Is the Test Done?
A healthcare professional will extract a blood sample from your arm using a small needle.
Preparing for the Test
Adhere to the instructions provided by your healthcare provider, which may include fasting for 8 to 12 hours prior to the test.
Risks Involved
A blood test carries minimal risks, with any discomfort typically resolving quickly.
Understanding Test Results
Elevated insulin levels alongside normal blood glucose levels may indicate insulin resistance. Abnormal levels could be due to an insulinoma or excess insulin usage. It is important to consult with your healthcare provider to discuss further testing and treatment options. Monitoring insulin levels regularly can help manage conditions related to insulin imbalance. Make sure to follow your provider’s recommendations for a healthy lifestyle and medication management.
Insulin Blood Test and C-Peptide
This test is often conducted alongside a C-peptide test to precisely measure the pancreas’s insulin production.
Inadequate insulin production or functioning can result in high blood sugar levels. Missing insulin doses or consuming excess carbohydrates may lead to hyperglycemia.
Accumulation of sugar in the blood due to limited insulin action may cause symptoms such as frequent urination, excessive thirst, fatigue, and unexplained weight loss.
Causes of High Blood Sugar
- Missing medication doses.
- Excessive carbohydrate intake.
- Stress, illness, or steroid use.
- Unnoticed bodily reactions.
Symptoms of Hyperglycemia
- Frequent urination, thirst, fatigue.
- Bladder and skin infections.
- Headaches, blurred vision, weight loss.
- Slow healing of cuts and wounds.
- Irritability, mood changes.
Managing High Blood Sugar
Regularly monitor blood sugar levels if they exceed the normal range. Check for ketones and consult your healthcare team for appropriate measures. Ensure adequate hydration and follow guidance during illnesses.
If blood sugar levels consistently surpass 10mmol/l, contact your diabetes team or GP for assessment and advice on lowering levels, possibly through medication adjustments.
Can drinking a lot of water lower your blood sugar levels?
Staying hydrated aids in reducing blood sugar levels but may not suffice for high levels. Persistent high levels may necessitate medication adjustments as recommended by your diabetes team.
How to prevent hyperglycaemia
Routine monitoring of blood sugar levels and preventive measures against highs may involve:
- Following guidelines for sickness
- Monitoring carbohydrate intake and opting for lower GI foods
- Including more fiber in your diet
- Maintaining or managing weight
- Staying physically active
Additionally, managing stress, emotional well-being, and ensuring sufficient sleep are crucial for stabilizing blood sugar levels.
If you regularly have high blood sugar levels
Persistent high blood sugar raises the risk of diabetes complications. If levels consistently exceed target ranges, seek advice from your diabetes team for potential medication adjustments.
In addition to medication adjustments, lifestyle changes such as regular exercise, a healthy diet, and monitoring your blood sugar levels can also help manage high blood sugar. It’s important to work closely with your healthcare team to develop a personalized plan that works best for you.
Getting support
If managing diabetes becomes challenging, seek support through helplines or forums for guidance and shared experiences.
An insulin blood test gauges insulin levels in your blood, regulating glucose movement for energy. Imbalances can lead to hypoglycemia or hyperglycemia, warranting medical attention.
What is it used for?
Insulin tests aid in diagnosing causes of hypoglycemia, identifying insulin resistance, guiding type 2 diabetes treatment decisions, and monitoring outcomes of pancreatic islet cell transplants.
Furthermore, insulin tests are crucial in managing gestational diabetes, assessing risk factors for cardiovascular diseases, and evaluating metabolic disorders such as polycystic ovary syndrome (PCOS). These tests also play a role in monitoring insulin therapy effectiveness and adjusting medication dosages for individuals with insulin-dependent diabetes.
Why do I need an insulin blood test?
An insulin test is important for assessing your body’s ability to regulate glucose levels. Insulin is a hormone that helps control blood sugar levels by allowing your cells to take in glucose from the bloodstream. If you have low blood glucose or symptoms of hypoglycemia, an insulin test can help determine if there is an issue with insulin production or sensitivity. In addition, if you have conditions like prediabetes or type 2 diabetes, monitoring your insulin levels can help in managing your condition and preventing complications. Overall, an insulin blood test provides valuable information about your overall health and can help in diagnosing and managing various health conditions related to blood glucose regulation.
What happens during an insulin in blood test?
A blood sample is gathered from the arm for the test using a small needle.
Will I need to do anything to prepare for the test?
Prepare for the test by fasting for 8-12 hours and potentially discontinuing biotin supplements. Consult your provider before halting any medications. It is also important to drink plenty of water before the test to stay hydrated and help with the blood draw process.
Are there any risks to the test?
Associated risks with blood tests are minimal, with common temporary discomfort or bruising at the needle insertion site.
What do the results mean?
Interpretation of insulin test findings considers your medical history and other tests like blood glucose levels to determine the next appropriate steps.
- If insulin levels are high and blood glucose levels are normal or slightly elevated, insulin resistance may be present.
- If insulin levels are high or normal and blood glucose is low, excessive insulin might cause hypoglycemia. Potential causes include:
- A pancreatic tumor (insulinoma)
- Excess insulin intake for diabetes
Various factors can lead to abnormal insulin and glucose levels. For detailed insights into your health based on test results, consult your provider.
Is there anything else I should know about an insulin in blood test?
An insulin blood test is often paired with a C-peptide test for a more precise evaluation of pancreatic insulin production.
Insulin functions within a narrow physiological range alongside other hormones. Elevated or deficient systemic insulin levels can impact bodily functions.
Main body
Insulin plays a crucial role in glucose regulation, acting as an anabolic hormone that stimulates various cellular responses. Excessive insulin levels may lead to diverse health issues.
Background
Most hormones require an optimal concentration range for proper bodily functions. Deviations from this range can result in health conditions necessitating treatment.
Hormones are signaling molecules that play a crucial role in regulating various physiological processes in the body. They are produced by endocrine glands and travel through the bloodstream to target cells where they exert their effects. Imbalances in hormone levels can lead to a wide range of health issues, including thyroid disorders, reproductive issues, and metabolic imbalances. It is important to monitor hormone levels regularly to ensure proper functioning of the body and to address any abnormalities promptly.
Main text
Insulin signaling pathways
Insulin binding to its receptor triggers signaling pathways affecting anabolic processes. Metabolic signaling through insulin involves multiple pathways that enhance glucose utilization and other metabolic functions.
Insulin secretion
Insulin secretion by pancreatic β cells responds to nutrients in the bloodstream, regulating glucose balance. Circulating insulin levels influence energy use and fat storage.
Insulin promotes obesity
Historically, insulin injections have been used in non-diabetic individuals with malnutrition to aid in energy storage. Insulin levels directly impact processes like lipolysis and adipogenesis.
Studies indicate that high fasting insulin levels in children and adolescents correlate with higher weight gain later in life. Findings in adults show less consistent results. Interventions lowering insulin secretion through pharmaceuticals lead to notable weight loss. This aligns with observations that insulin therapy contributes to weight gain. Transient increases in metabolic or immune mediator levels are viewed as benign physiological responses, but chronic elevations usually have adverse effects. Prolonged elevated insulin levels can disrupt various cell types through diverse pathways.
In mice studies, reducing insulin concentrations resulted in resistance to weight gain despite a high-fat diet. Lowering insulin gene expression reversed obesity induced by diet. An insulin gene region polymorphism was tied to higher fasting insulin levels and faster weight gain in obese individuals. Higher genetically determined insulin secretion correlated with increased BMI. Moderate to high normal insulin levels in metabolically healthy individuals pose a risk for obesity development.
Elevated insulin concentrations impair cellular functions—insulin “toxicity”
Chronic exposure to elevated insulin levels disrupts cellular responses, favoring protein synthesis while suppressing autophagy, leading to cellular senescence. Prolonged exposure to high insulin levels can be toxic to cells, impairing defense mechanisms and causing DNA damage. Hyperinsulinemia may impair brain function and result in cognitive decline.
Chronically elevated insulin concentrations impair body functions
Longevity
The negative cellular responses to high insulin levels suggest impairments affecting longevity at the organism level. Studies in nonvertebrate models illustrate that increased insulin activity shortens lifespan. Models show that reduced signaling from anabolic hormones result in prolonged lifespan. Genetic disruptions causing insulin resistance lead to extending lifespan. Lowering insulin levels in mice prolonged lifespan and improved metabolic parameters.
Insulin, IGF-1, and their hybrid receptors activate the PI3K/AKT pathway, leading to mTORC1 activation, which impacts growth, protein synthesis, and lifespan. Studies have shown that suppressing mTOR with rapamycin can extend lifespan in both animals and humans. Furthermore, maintaining low insulin and glucose levels is associated with healthy aging.
Both insulin and IGF-1 signal through the PI3K/AKT pathways, influencing longevity. Lowering insulin levels selectively has been shown to improve lifespan in rodents. When it comes to healthy aging, insulin and glucose seem to play a more significant role than IGF-1.
Insulin resistance occurs when there is impaired glucose clearance into tissues, leading to elevated insulin levels. Hyperinsulinemia, caused by insulin resistance, can have adverse effects on health. Increased insulin levels and insulin resistance are linked to higher risks of cardiovascular issues.
Insulin has an impact on arterial function through regulating NO production and calcium homeostasis. Higher insulin levels and insulin resistance are associated with an increased risk of cardiovascular diseases. Insulin also affects gene expression and inflammatory signaling, while the renin-angiotensin system contributes to vascular stiffening.
Elevated insulin levels are linked to an increased risk of hypertension through sodium reabsorption signaling. The likelihood of hypertension is higher with elevated insulin levels or insulin resistance. Prolonged insulin treatment can lead to arterial lesions and atherosclerosis. Macrophage activity and lipoprotein lipase also play a role in the development of arterial plaque.
During the late 1960s, concerns arose about hyperinsulinemia potentially contributing to arterial disease in diabetic individuals. Despite improved glycemia and reduced risk of ketosis with insulin therapy, incidences of atherosclerosis were on the rise. More recent data suggests that insulin resistance is a marker of higher cardiovascular disease risk in both the general population and diabetic patients. Although intensive glycemic control through insulin therapy has not been proven to reduce the risk of cardiovascular events and could even increase it, studies indicate that metformin, an oral therapy, may reduce the risk of cardiovascular events, along with insulin resistance and hyperinsulinemia.
Observations consistently show that introducing insulin or intensifying insulin treatment in patients with type 2 diabetes can result in a higher number of cardiovascular events, especially with increased insulin doses. While some limitations exist, such as difficulties in accounting for disease stage or hypoglycemic events, these studies cover numerous potential risk factors. Large randomized trials like UKPDS have not found an increased incidence of cardiovascular disease with low-dose insulin therapy. However, the higher-dose therapy commonly used in real-world conditions has not been studied extensively. Some real-world research reports that significant daily insulin doses are given to type 2 diabetic patients.
Mendelian randomization studies have utilized genetic associations with fasting insulin levels to link hyperinsulinemia to health issues like elevated blood pressure, cardiovascular disease, and type 2 diabetes. Prolonged high insulin levels activate various cellular pathways contributing to negative health outcomes, including obesity, hypertension, myocardial infarction, and reduced lifespan. Strategies to reduce insulin levels include calorie control, exercise, and bariatric surgery.
Maintaining low fasting or circadian insulin levels is essential for healthy living. Therefore, careful consideration should be given to insulin treatment for type 2 diabetes to prevent hyperinsulinemia and related insulin resistance.
Evidence suggests that hormesis may play a role in defending against type 2 diabetes. Glucose damage has been studied extensively, highlighting the impact on the pancreas and beta-cells. Furthermore, endothelial toxicity in diabetic kidney disease has been linked to high glucose levels. Insulin resistance can harm Akt activity, affecting glucose entry in human muscle cells. Insulin resistance is seen as an antioxidant protection mechanism, with implications for fuel overload and metabolic disorders. Specific pathways, such as the PI3K pathway, are involved in insulin resistance and metabolic stress. Additionally, the impact of insulin therapy on cardiovascular outcomes in type 2 diabetes patients has been investigated. Overall, these studies shed light on the intricate relationship between insulin, metabolism, and disease.
Long-term survival rates in individuals diagnosed with type 2 diabetes who have undergone coronary angiography may be influenced by the type of glucose-lowering treatment received, according to a study published in Diabetologia in 2012.
The Lancet published UK Prospective Diabetes Study (UKPDS) in 1998, emphasizing the importance of intensive blood-glucose control in reducing the risk of complications in patients with type 2 diabetes.
In a study published in the New England Journal of Medicine in 2012, the use of basal insulin was associated with various cardiovascular outcomes in individuals with dysglycemia.
A real-world study published in the Canadian Journal of Diabetes in 2019 compared the health outcomes of adults with type 1 and type 2 diabetes treated with insulin glargine 300 U/mL versus insulin glargine 100 U/mL.
A retrospective observational study published in Advances in Therapy in 2018 analyzed treatment dosing patterns and clinical outcomes in patients with type 2 diabetes initiating or switching to insulin glargine (300 units per milliliter) in a real-world setting.
The effectiveness of insulin degludec following a switch from basal insulin in individuals with type 1 or type 2 diabetes was evaluated in a European, multicentre study published in Diabetes, Obesity and Metabolism in 2018.
A study published in Diabetes in 2014 provided genetic evidence for a normal-weight “metabolically obese” phenotype that links insulin resistance, hypertension, coronary artery disease, and type 2 diabetes.
A sex-specific Mendelian randomization study published in Communications Biology in 2019 looked at genetically predicted insulin levels and cardiovascular events in the UK Biobank population.
In a 2012 publication in Diabetes Care, the hypothesis of insulin hypersecretion and the role of food additives as potential causes of obesity and diabetes were discussed.
The 2-year outcomes of a primary care-led weight-management intervention for inducing remission of type 2 diabetes were reported in the Lancet Diabetes and Endocrinology in 2019.
A randomized controlled trial published in Diabetes Care in 2017 assessed the efficacy of the telemedical lifestyle intervention program TeLiPro in individuals with advanced stages of type 2 diabetes.
The impact of intermittent fasting on various health and disease processes was reviewed in a 2017 publication in Ageing Research Reviews.
Research published in PLoS One in 2016 indicated that acute exercise could enhance insulin clearance and increase the expression of insulin-degrading enzymes in the liver and skeletal muscle.
Metabolic surgery and its effects on weight loss, diabetes management, and other factors were discussed in a study published in the Journal of the American College of Cardiology in 2018.
A prospective evaluation of insulin and incretin dynamics following Roux-en-Y gastric bypass in obese adults with and without diabetes was conducted over a 2-year period and published in Diabetologia in 2018.
Hyperinsulinemia was highlighted as an early indicator of metabolic dysfunction in a study published in the Journal of the Endocrine Society in 2019.
Recommendations for the management of hyperglycemia in individuals with type 2 diabetes were outlined in a comprehensive publication in Diabetes Care in 2018.